Evogliptin HCl

CAS No. : 1246960-27-9 (HCl).

Evogliptin HCl,1246960-27-9 (HCl).
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I006744
Synonyms:DA-1229; DA 1229; DA1229; Evogliptin; Evogliptin hydrochloride.;(R)-4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one hydrochloride
Molecular Formula:C19H27ClF3N3O3
Molecular Weight:437.8882
Target:DPP4 inhibitor
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

Appearance:Solid powder
Purity: > 98%
Cat No:I006744
Cas No:1246960-27-9 (HCl).
Product-Name:Evogliptin HCl
Evogliptin, also known as DA-1229, is a potent and selective DPP4 inhibitor (dipeptidyl peptidase 4 inhibitor). Evogliptin improves insulin resistance and delays the onset of diabetes. Evogliptin improves the insulin sensitivity in HF mice and delays the onset of diabetes in young db/db mice. DA-1229 monotherapy (5 mg for 12 weeks) improved HbA1c, fasting plasma glucose level, OGTT results and β-cell function. This drug was well tolerated in Korean subjects with type 2 diabetes mellitus.

1:Jung CH, Park CY, Ahn KJ, Kim NH, Jang HC, Lee MK, Park JY, Chung CH, Min KW, Sung YA, Park JH, Kim SJ, Lee HJ, Park SW. A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. Diabetes Metab Res Rev. 2015 Mar;31(3):295-306. doi: 10.1002/dmrr.2613. Epub 2014 Dec 5. PubMed PMID: 25362864; PubMed Central PMCID: PMC4670720.
Related Products
  • CAS No. :890402-81-0 (tartrate salt)
    Product Name:

    Dutogliptin tartrate

    Cat No: I006559 View details
  • CAS No. :851389-35-0
    Product Name:


    Cat No: I002955 View details